The populations with the greatest disparities are adolescents, Black and Hispanic patients, and those with public or no insurance.

Accessible testing for the infections may help curb the STI epidemic, but there is still a long way to go. By Laura Baisas Published Nov 28, 2023 3:30 PM EST Get the Popular Science daily newsletter💡 ...

Americans looking to stay on top of their sexual health have a new at-home option available to them. Earlier this month, the Food and Drug Administration authorized the first home test for chlamydia ...

Credit: LetsGetChecked. The Simple 2 Test can detect the presence of Chlamydia trachomatis and Neisseria gonorrhoeae through samples collected at home from vaginal swabs and urine specimens. The Food ...

The first home test for chlamydia and gonorrhea will soon hit the market, following its approval Wednesday by the U.S. Food and Drug Administration. People will be able to buy the Simple 2 Test ...

Recent statistics show that the incidence of sexually transmitted infections (STIs) continues to rise. In 2021 alone, over 2.5 million cases of chlamydia, gonorrhea, and syphilis were reported. The ...

The program is powered by the binx io, an FDA-cleared, CLIA-waived, molecular PCR chlamydia and gonorrhea ~30-minute test for male and female patients. Together, WellStreet Urgent Care and binx health ...

Sexually transmitted infections, or STIs, include both sexually transmitted diseases, known as STDs, and the many infections that don’t progress to disease. STIs are caused by more than 30 different ...

The Food and Drug Administration granted marketing approval to a home test for chlamydia and gonorrhea on Wednesday, the first such authorization of a home test to detect the two most common sexually ...

The FDA on Wednesday granted marketing authorization to the first chlamydia and gonorrhea test that allows for at-home sample collection. Intended for adults, the over-the-counter (OTC) Simple 2 test ...